M3, Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020
January 28, 2020 at 01:00 am EST
Share
M3, Inc. reported consolidated earnings results for the nine months ended December 31, 2019. For the period, the company reported net sales of ¥96,319 million against ¥83,674 million a year ago. Operating profit was ¥26,933 million against ¥22,958 million a year ago. Net profit was ¥18,616 million against ¥15,976 million a year ago. Basic earnings per share were ¥24.45 against ¥22.50 a year ago. Diluted earnings per share were ¥24.44 against ¥22.49 a year ago.
For the year ending March 31, 2020, the company expects consolidated net sales of ¥130,000 million, operating profit of ¥35,000 million, net profit of ¥24,000 million and basic earnings per share of ¥32.43.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, Inc. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020
M3, INC. 
